Patients with GDM have systemic inflammatory response (34, 35), and the inflammatory factors C-reactive protein (CRP) and monocyte chemoattractant protein-1 (MCP-1) are significantly increased in patients with GDM, which are involved in the occurrence and development of GDM (36, 37). This evidence concerns the gene CRP and gestational diabetes.